SEptal Scoring Along Midline Endocardium (SESAME) achieved 100% technical success for myocardial laceration with 97.4% procedural survival and improved predicted post-TMVR LVOT area (P<0.001).
Observational (n=76)
No
Does the SESAME transcatheter electrosurgical procedure improve LVOT area and gradients in patients with LVOT obstruction or those undergoing TMVR/TAVR?
76 patients with symptomatic LVOT obstruction or requiring space creation to facilitate TMVR or TAVR treated in a single-center retrospective study.
SEptal Scoring Along Midline Endocardium (SESAME) transcatheter electrosurgical procedure
Technical success of SESAME myocardial laceration, changes in predicted post-TMVR LVOT (neo-LVOT and skirt-neo-LVOT), and invasive LVOT gradientssurrogate
The novel SESAME transcatheter electrosurgical procedure successfully reduces LVOT obstruction in HCM and increases LVOT area to facilitate TMVR/TAVR with an acceptable safety profile.
Background Left ventricular outflow tract (LVOT) obstruction is a source of morbidity in hypertrophic cardiomyopathy (HCM) and a life-threatening complication of transcatheter mitral (TMVR) and aortic valve replacement (TAVR). Available surgical and transcatheter approaches are limited by high surgical risk, unsuitable septal perforators, and heart block requiring permanent pacemakers. Objectives We report the initial experience of a novel transcatheter electrosurgical procedure developed to mimic surgical myotomy. Methods We used SEptal Scoring Along Midline Endocardium (SESAME) to treat patients, on a compassionate basis, with symptomatic LVOT obstruction or to create space to facilitate TMVR or TAVR. Results In this single-center retrospective study between 2021–2023, 76 patients underwent SESAME. Eleven (14%) had classic HCM, and the remainder underwent SESAME to facilitate TMVR or TAVR. All had technically successful SESAME myocardial laceration. Measures to predict post-TMVR LVOT significantly improved (neo-LVOT 42(7,117)to 170(95,265)mm2,p<0.001; skirt-neo-LVOT 169(153,193) to 214(180,262)mm2,p<0.001). Among patients with HCM, SESAME significantly decreased invasive LVOT gradients (resting: 5440,70 to 2912,36mmHg,p=0.023; provoked 146100,180 to 8540,120mmHg,p=0.076). Seventy-four (97.4%) survived the procedure. Five suffered 3/76(3.9%) iatrogenic ventricular septal defects that did not require repair, and 3/76(3.9%) ventricular free wall perforations. Neither occurred in patients treated for HCM. Permanent pacemakers were required in 4/76(5.3%), including two after concomitant TAVR. Lacerations were stable and did not propagate after SESAME (remaining septum: 5.9±3.3mm to 6.1±3.2mm,p=0.8). Conclusions With further experience, SESAME may benefit patients requiring septal reduction therapy for obstructive hypertrophic cardiomyopathy, with LVOT obstruction after heart valve replacement, and/or to prepare for transcatheter valve implantation.
“There's a steep learning curve and the technique still requires refinement. If you've seen these live cases, it's usually two operators in a biplane lab yelling at the imager back and forth. But we believe with purpose-built, designed devices that we could do this in a single plane, single operator, with less dependance on a supernatural echocardiographer.”
Building similarity graph...
Analyzing shared references across papers
Loading...
Adam B. Greenbaum
Structural Heart Disease
Hiroki Ueyama
Beth Israel Deaconess Medical Center
Patrick Gleason
Emory University Hospital Midtown
Journal of the American College of Cardiology
University of Washington
National Institutes of Health
National Heart Lung and Blood Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Greenbaum et al. (Mon,) conducted a observational in Left ventricular outflow tract (LVOT) obstruction (n=76). SEptal Scoring Along Midline Endocardium (SESAME) was evaluated on Technically successful SESAME myocardial laceration. SEptal Scoring Along Midline Endocardium (SESAME) achieved 100% technical success for myocardial laceration with 97.4% procedural survival and improved predicted post-TMVR LVOT area (P<0.001).
synapsesocial.com/papers/6a27da8c6eaa588fbbf7688b — DOI: https://doi.org/10.1016/j.jacc.2024.02.007